Transgene S.A.

Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip 's global team, in this podcast version of Five Must-Know Things. This ep

French biotech company Transgene has endured multiple setbacks over the last 15 years as it tries to develop ”cancer vaccines” to stimulate an immune response to tumors, but its new CEO, Alessandro

Major Japanese technology firm NEC Corporation has expanded its presence in the pharmaceutical industry in Europe, establishing two additional operations in the biopharmaceutical sector at the end o

After teetering on the brink of delisting, the fortunes of SillaJen, Inc. appear to be reviving after the Korea Exchange decided the South Korean bioventure could continue to trade on the Kosdaq mar